Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
API plant
Manufacturing
Indian API maker Cdymax hit with warning letter tied to testing
The letter comes in response to an earlier Form 483 the FDA issued after inspecting Cdymax's facility from April 21-25.
Joseph Keenan
Nov 20, 2025 9:27am
Cambrex to drop $120M to expand US operations
Oct 23, 2025 9:25am
AZ breaks ground on $4.5B API production facility in Virginia
Oct 9, 2025 1:45pm
Lilly reveals plan for $5B API production facility in Virginia
Sep 16, 2025 10:30am
Garonit Pharma plans $46.1M antiseptic product plant in New York
Aug 7, 2025 8:55am
Lilly weighs Houston as option for new $5.9B API facility
May 19, 2025 10:21am
